Kazia Therapeutics LTD (KZIA) SEC Filings — 2024
26 SEC filings for Kazia Therapeutics LTD (KZIA) in 2024.
Filings
- Kazia Therapeutics Files 6-K Report — 6-K · Dec 31, 2024
- Kazia Therapeutics Files 6-K Report — 6-K · Dec 11, 2024
- Kazia Therapeutics Files 20-F for FY24 — 20-F · Nov 15, 2024
- Kazia Therapeutics LTD SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Kazia Therapeutics Files Routine 6-K Report — 6-K · Nov 12, 2024
- Kazia Therapeutics LTD SC 13G Filing — SC 13G · Nov 6, 2024
- Kazia Therapeutics Files Routine 6-K — 6-K · Nov 4, 2024
- Kazia Therapeutics Changes ADS to Ordinary Share Ratio — 6-K · Oct 15, 2024
- Kazia Therapeutics Files 6-K Report — 6-K · Oct 2, 2024
- Kazia Therapeutics Files 6-K with SEC — 6-K · Sep 23, 2024
- Kazia Therapeutics Files Form 6-K — 6-K · Sep 13, 2024
- Kazia Therapeutics LTD SC 13G/A Filing — SC 13G/A · Aug 12, 2024
- Kazia Therapeutics Files Routine 6-K Report — 6-K · Jul 10, 2024
- Kazia Therapeutics LTD SC 13G Filing — SC 13G · Jul 2, 2024
- Kazia Therapeutics Files June 2024 6-K Report — 6-K · Jun 24, 2024
- Kazia Therapeutics Faces Nasdaq Listing Deficiency — 6-K · May 23, 2024
- Kazia Therapeutics Reports on Warrant Issuance — 6-K · May 17, 2024
- Kazia Therapeutics Files 6-K Report — 6-K · May 1, 2024
- Kazia Therapeutics Secures $10M Stock Purchase Agreement — 6-K · Apr 19, 2024
- Kazia Therapeutics Files 6-K for Q2 2023 — 6-K · Mar 27, 2024
- Kazia Therapeutics Files 6-K Report — 6-K · Mar 26, 2024
- Kazia Therapeutics Files 6-K, Confirms 20-F Annual Reporting — 6-K · Feb 21, 2024
- Kazia Therapeutics LTD SC 13G Filing — SC 13G · Feb 14, 2024
- Platinum IM Discloses 6.91% Stake in Kazia Therapeutics — SC 13G · Feb 12, 2024
- Kazia Therapeutics Appoints Robert Apple to Board, Bolstering Leadership — 6-K · Jan 18, 2024
- Kazia Therapeutics: CFO Resigns, New Financial Officer Appointed — 6-K · Jan 12, 2024